10 Top Drugs Now or Soon With Generic Equivalents

Cymbalta Cymbalta

Used for: Depression

Manufactured by: Lilly

Estimated annual sales: $4.7 billion

Generic: duloxetine

Generic launch date: December 2013

Lidoderm 5% Lidoderm 5%

Used for: Skin conditions

Manufactured by: Endo

Estimated annual sales: $1.3 billion

Generic: lidocaine topical patch

Generic launch date: September 2013

Niaspan Niaspan

Used for: High blood cholesterol

Manufactured by: AbbVie

Estimated annual sales: $1.2 billion

Generic: niacin, extended release

Generic launch date: September 2013

AcipHex AcipHex

Used for: Ulcer disease

Manufactured by: Eisai

Estimated annual sales: $901 million

Generic: rabeprazole

Generic launch date: November 2013

Suboxone Sublingual Tablets Suboxone Sublingual Tablets

Used for: Pain

Manufactured by: Reckitt Benkiser

Estimated annual sales: $697 million

Generic: buprenorphine/naloxone

Generic launch date: February 2013

Nexium Nexium

Used for: Ulcer disease

Manufactured by: AstraZeneca

Estimated annual sales: $6.1 billion

Generic: esomeprazole

Generic launch date: May 2014

Copaxone 20 mg/mL Copaxone 20 mg/mL

Used for: Mental/neurological disorders

Manufactured by: Teva

Estimated annual sales: $3.7 billion

Generic: glatiramer acetate

Generic launch date: May 2014

Diovan Diovan

Used for: High blood pressure/heart disease

Manufactured by: Novartis

Estimated annual sales $2.1 billion

Generic: valsartan

Generic launch date: Mid-2014

Renvela Renvela

Used for: Gastrointestinal disorders

Manufactured by: Genzyme

Estimated annual sales: $889 million

Generic: sevelamer carbonate

Generic launch date: March 2014

Lunesta Lunesta

Used for: Sleep disorders

Manufactured by: Sunovion

Estimated annual sales: $852 million

Generic: eszopiclone

Generic launch date: April 2014

Overall spending on traditional prescription drugs -- mostly pills used to treat common conditions such as high cholesterol and depression -- will decline 4% by the end of 2015, largely because of the availability of generic medications, according Express Scripts. Here are 10 of the top brand-name drugs that had generic equivalents become available in 2013 or are expected to have generics available this year, courtesy of Express Scripts.

This presentation originated at Employee Benefit News. Photos from Shutterstock.

 

Already a subscriber? Log in here
Please note you must now log in with your email address and password.